PIK3CA and non-small cell lung carcinoma: Importantly, EGCG was able to modulate microRNA expressions to inhibit the activity of several signaling pathways such as MAPK, PI3K, Wnt, SHH, and TGFβ pathways to inhibit NSCLC’s growth and proliferation [125].